Skip to main content
NIH Record - National Institutes of Health
A microscopic view of an antiretroviral drug

October 27, 2023

  • Premier Intramural Science Event Back Bigger Than Ever

    The 2023 NIH Research Festival certainly made up for lost time—essentially three years lost time, due to the Covid-19 pandemic that shuttered a lot of in-person work by NIH’s Intramural Research Program (IRP) and halted the 33-year stretch of on-campus science festivals. “We are part of an incredible history,” said NIH Deputy Director for Intramural Research Dr. Nina Schor.
  • Sandler talks into microphone at podium in Lipsett Amphitheater

    NIEHS’s Sandler Expounds on Environmental Risks of Breast Cancer

    By Dana Talesnik

    Researchers have long attributed breast cancer to a combination of genetic, hormonal, lifestyle and environmental factors, though discerning precise environmental triggers remains tricky. A large, prospective NIH research effort called the Sister Study continues to shed light on those triggers. NIEHS's Dr. Dale Sandler discusses the study at this year's Research Festival.
  • Man in plaid shirt explains his research poster to onlookers

    Scientists Showcase Findings at Festival Poster Sessions

    By myranda tarr

    Dozens of NIH researchers gathered in the FAES Terrace at the Clinical Center to present their recent studies during the NIH Research Festival Poster Sessions on Sept. 18 and 19.
  • Dr. David Kosub

    NIH’ers Discuss Proposed Changes to Mission Statement

    By David Kosub

    NIH’s mission statement is going under the microscope again. In August, Acting NIH Director Dr. Lawrence Tabak announced proposed changes, saying it is “important that the mission statement accurately reflects NIH’s goal of turning scientific discoveries into better health for all.” The step follows a recommendation by the advisory committee to the director working group on diversity’s subgroup on individuals with disabilities.
A microscopic view of an antiretroviral drug

On the Cover

Polarized crystals (photographed through a microscope) of the drug 2-3 dideoxyadenosine, also known as ddA, a drug that is closely related to AZT or azidothymidine. The antiviral effect of ddA against HIV was discovered at the National Cancer Institute.

Photo: Larry Ostby, NCI

Back to Top